download chevron-down chevron-right chevron-with-circle-down chevron-with-circle-up check circle-with-minus circle-with-plus export help-with-circle inbox link mail old-phone star-outlined star user v-card close close close Back to top
Top

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

CMS Measure ID
CMS22v6
Version
6
NQF Number
None
Measure Description

Percentage of patients aged 18 years and older seen during the reporting period who were screened for high blood pressure AND a recommended follow-up plan is documented based on the current blood pressure (BP) reading as indicated

Initial Population

All patients aged 18 years and older before the start of the measurement period with at least one eligible encounter during the measurement period

Denominator Statement
Denominator Exclusions

Patient has an active diagnosis of hypertension

Numerator Statement

Patients who were screened for high blood pressure AND have a recommended follow-up plan documented, as indicated if the blood pressure is pre-hypertensive or hypertensive

Numerator Exclusions

Not Applicable

Denominator Exceptions

Patient Reason(s):

Patient refuses to participate (either BP measurement or follow-up)

OR

Medical Reason(s):

Patient is in an urgent or emergent medical situation where time is of the essence and to delay treatment would jeopardize the patient's health status. This may include but is not limited to severely elevated BP when immediate medical treatment is indicated.

Next Version
Measure Scoring
Measure Type
Improvement Notation

Higher score indicates better quality

Guidance

Both the systolic and diastolic blood pressure measurements are required for inclusion. If there are multiple blood pressures on the same date of service, use the most recent as the representative blood pressure.

Eligible professionals or eligible clinicians who report the measure must perform the blood pressure screening at the time of a qualifying visit by an eligible professional or eligible clinician and may not obtain measurements from external sources.

The intent of this measure is to screen patients for high blood pressure and provide recommended follow-up as indicated. The documented follow-up plan must be related to the current BP reading as indicated, example: "Patient referred to primary care provider for BP management."

Notes

Value Set content updated Sept 2017

Specifications

Release Notes

Header

  • ​Incremented eMeasure Version number.

    Measure Section: eMeasure Version number

    Source of Change: Measure Lead

  • Modified Measure Developer name from 'Quality Insights of Pennsylvania' to 'Quality Insights.'.

    Measure Section: Measure Developer

    Source of Change: Measure Lead

  • ​Updated Copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Updated Guidance.

    Measure Section: Guidance

    Source of Change: Measure Lead

  • Updated References.

    Measure Section: Reference

    Source of Change: Measure Lead

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Value set Laboratory Tests for Hypertension (2.16.840.1.113883.3.600.1482): Added 1 LOINC code (24320-4).

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set BP Screening Encounter Codes (2.16.840.1.113883.3.600.1920): Deleted 7 CPT codes (90832, 90834, 90837, 90839, 90845, 90880, 96118).

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set Anti-Hypertensive Pharmacologic Therapy (2.16.840.1.113883.3.600.1476): Added 12 RXNORM codes and deleted 18 RXNORM codes.

    Measure Section: QDM Data Elements

    Source of Change: Annual Update

  • Value set Anti-Hypertensive Pharmacologic Therapy (2.16.840.1.113883.3.600.1476): Added 4 RXNORM codes (1923422, 1923424, 1923426, 901446) and deleted 28 RXNORM codes.

    Measure Section: QDM Data Elements

    Source of Change: 2018 Addendum

Last Updated: Aug 19, 2019